⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of China Meheco Corporation and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
China Meheco Corporation
↗Beijing, China
China Meheco Group Co., Ltd. is a major state-owned pharmaceutical and healthcare enterprise in China, operating under the China General Technology (Group) Holding Co., Ltd. (Genertec). The company is vertically integrated, covering R&D, cultivation, manufacturing, distribution, logistics, and international trade of pharmaceuticals, medical devices, and health products.
Established in 1983 as the China National Medicines and Health Products Import and Export Corporation, it serves as a key platform for Genertec's medical and health industry. The company is listed on the Shanghai Stock Exchange (600056.SH) and maintains an extensive domestic and international network, acting as both a manufacturer and a leading distributor of drugs and medical equipment.
CLASSIFICATION
Company Type:Pharma
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Pharmaceutical Distribution & Manufacturing
SIZE & FINANCIALS
Employees:10000+
Founded:1983
Ownership:public
Status:operating
STOCK
Exchange:Shanghai Stock Exchange
Ticker:600056
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, Traditional Chinese Medicine
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:China General Technology (Group) Holding Co., Ltd.
Subsidiaries:China Meheco International Co., Ltd.
Key Partnerships:Ascletis Pharma (Distribution of ritonavir tablets), Daewoong Pharma (Drug export/import cooperation)
COMPETITION
Position:Leader
LEADERSHIP
Key Executives:
Yadong Li - Chairman
LINKS
Website:mehecointl.com.cn
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with China Meheco Corporation. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.